These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1271 related items for PubMed ID: 20512987

  • 21. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 22. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H, Wang J, Li W, Chen R, Chen X, Zhang F, Xu D, Lu F.
    J Clin Virol; 2018 Jan; 99-100():71-78. PubMed ID: 29353073
    [Abstract] [Full Text] [Related]

  • 23. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.
    Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK, Hall J, Lai CL.
    Hepatology; 2004 Sep; 40(3):727-37. PubMed ID: 15349913
    [Abstract] [Full Text] [Related]

  • 24. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P, Zhou B, Dai X, Sun Z, Guo X, Huang J, Gong Z.
    Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
    [Abstract] [Full Text] [Related]

  • 25. [Quantitative analyses of intrahepatic HBV cccDNA and serum HBsAg in 54 patients with chronic hepatitis B].
    Li WJ, Li BA, Zhao JM, Han JQ, Liu Y, Jiang L, Mao YL, Lu FM, Xu DP.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):815-7. PubMed ID: 22433301
    [Abstract] [Full Text] [Related]

  • 26. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B, Terpstra V, Zaaijer H, Weegink C, Dijkgraaf M, Jansen P, Beld M, Reesink H.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.
    Cheng PN, Tsai HW, Chiu YC, Ho CH, Wu IC, Chang TT.
    J Clin Virol; 2013 Aug; 57(4):323-30. PubMed ID: 23731848
    [Abstract] [Full Text] [Related]

  • 28. [Serum HBsAg concentration and HBV replication level in hepatitis B patients with positive serum HBsAg and HBeAg].
    Lei JH, Yang X, Luo HY, Wang WL, Huang L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):548-51. PubMed ID: 16951515
    [Abstract] [Full Text] [Related]

  • 29. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K, Kocamaz H, Doğan Y.
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [Abstract] [Full Text] [Related]

  • 30. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HLA, Gane E, Sozzi V, Colledge D, Hammond R, Edwards R, Locarnini S, Thompson A, Revill PA.
    Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
    [Abstract] [Full Text] [Related]

  • 31. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L, Cao X, Wang Z, Gao Y, Deng J, Liu X, Zhuang H.
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [Abstract] [Full Text] [Related]

  • 32. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
    Sun KX, Li J, Zhu FC, Liu JX, Li RC, Zhai XJ, Li YP, Chang ZJ, Nie JJ, Zhuang H.
    Vaccine; 2012 Aug 03; 30(36):5335-40. PubMed ID: 22749833
    [Abstract] [Full Text] [Related]

  • 33. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
    Zhao T, Li X, Yin W, Cai X, Zhang W, Chen F, Lai G, Huang A.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr 03; 22(4):260-5. PubMed ID: 25173223
    [Abstract] [Full Text] [Related]

  • 34. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
    Zhang XD, Ren S, Yu HB, Liu YL, Jin Y, Huang YX, Chen JM, Chen XY.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep 03; 19(9):674-7. PubMed ID: 22152382
    [Abstract] [Full Text] [Related]

  • 35. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels.
    Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Jeong ID, Bang SJ, Lee SH, Kim SR, Park NH.
    J Viral Hepat; 2012 Oct 03; 19(10):724-31. PubMed ID: 22967104
    [Abstract] [Full Text] [Related]

  • 36. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
    Tan Z, Li M, Kuang X, Tang Y, Fan Y, Deng G, Wang Y, He D.
    J Clin Virol; 2014 Apr 03; 59(4):228-34. PubMed ID: 24529415
    [Abstract] [Full Text] [Related]

  • 37. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct 03; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 38. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B.
    Kim YJ, Cho HC, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    Liver Int; 2011 Jul 03; 31(6):817-23. PubMed ID: 21645212
    [Abstract] [Full Text] [Related]

  • 39. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B, Mukhopadhya A, Kurian G.
    J Gastroenterol Hepatol; 2008 Nov 03; 23(11):1734-8. PubMed ID: 18713304
    [Abstract] [Full Text] [Related]

  • 40. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK, Seto WK, Fung J, Ip P, Huang FY, Lai CL, Yuen MF.
    Clin Gastroenterol Hepatol; 2013 Aug 03; 11(8):1004-10.e1. PubMed ID: 23376799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.